Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of oral corticosteroids in unilateral recurrent laryngeal nerve palsy after thyroidectomy
2018-001231-48Phase 3Completed
- Sponsor
- CHU de Poitiers
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of prednisone in Laryngeal Paralysis, sponsored by CHU de Poitiers. Primary endpoint: Complete remobilization of laryngeal palsy at Day 7. Started Mar 2018; status: completed.
02
Drugs
prednisone
03
Conditions
Laryngeal Paralysis
Beyond the preview
Go deeper on 2018-001231-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001231-48.